Results 161 to 170 of about 161,426 (290)

Differential G protein activation by the long and short isoforms of the dopamine D2 receptor

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose The dopamine D2 receptor is expressed as a short (D2S) and a long (D2L) isoform with 29 additional amino acids in the third intracellular loop. The D2S isoform shows higher presynaptic expression than the D2L isoform, and decreased D2S expression has recently been linked to an increased risk for schizophrenia.
David Reiner‐Link   +4 more
wiley   +1 more source

Predictors of Mortality in Patients With Multiple Endocrine Neoplasia Type 1

open access: yesClinical Endocrinology, EarlyView.
SUMMARY Objective Multiple Endocrine Neoplasia Type 1 (MEN 1) is an autosomal dominant disease predisposing to hyperplasia and neoplasia in diverse endocrine tissues. Patients typically present with endocrine abnormalities before the age of 30 years and have reduced life expectancy.
Jasmine J. Zhu, John R Burgess
wiley   +1 more source

Endoscopic thyroidectomy via oral vestibular approach versus areolar approach: A meta-analysis

open access: yesAsian Journal of Surgery, 2023
Baoying Xia   +7 more
doaj  

Mega solid bone cyst in iliac region from primary hyperparathyroidism: a case report. [PDF]

open access: yesJ Med Case Rep
Campo FR   +8 more
europepmc   +1 more source

The latest evidence and guidance in lifestyle and surgical interventions to achieve weight loss in people with overweight or obesity

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue S2, Page 20-34, April 2025.
ABSTRACT Background The prevalence of obesity and related co‐morbidities has reached epidemic proportions. Effective evidence‐based treatment approaches are therefore important. Lifestyle intervention remains the mainstay of the treatment strategy to manage obesity.
Iskandar Idris, Oluwaseun Anyiam
wiley   +1 more source

GLP‐1 receptor agonists and the risk for cancer: A meta‐analysis of randomized controlled trials

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To assess if there is a difference in the oncogenic risk between GLP‐1 RA and comparators in randomized controlled trials. Materials and Methods A meta‐analysis of randomized controlled trials comparing GLP‐1RA to any comparators for diabetes and/or obesity, lasting at least 52 weeks.
Giovanni Antonio Silverii   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy